Genome Editing Market Size, Share, Industry, Forecast and Outlook (2024-2031)
Genome Editing Market
The Genome Editing Market is anticipated to grow at a significant compound annual growth rate (CAGR) during the forecast period from 2024 to 2031
Genome editing involves modifying an organism's DNA by inserting, deleting, or replacing genetic material to treat specific diseases. This process utilizes engineered nucleases, often referred to as molecular scissors, to create precise double-stranded breaks at targeted locations within the genome. The resulting breaks are then repaired through mechanisms such as non-homologous end joining or homologous recombination, leading to targeted genetic mutations or edits.
Sample Report: https://www.datamintelligence.com/download-sample/genome-editing-market
Genome Editing Market outlook
The global genome editing market is experiencing significant growth, driven by the increasing adoption of CRISPR genome editing technology and the rising demand for synthetic genes across various biotechnology sectors. The extensive use of genome editing in personalized medicine has also been a key factor in market expansion.
Personalized medicine allows healthcare professionals to tailor treatments to individual patient needs, leading to cost savings, improved patient compliance, early disease detection, and optimized therapy Additionally government funding, an increase in genomics projects, and a rise in the prevalence of cancer and other
genetic disorders are further propelling market growth. The development of novel CRISPR-based diagnostic tools, particularly in response to the COVID-19 pandemic, is also boosting the market. For instance, in March 2021, researchers from Nanyang Technological University developed VaNGuard (Variant Nucleotide Guard), a CRISPR-based diagnostic test that can detect mutated strains of SARS-CoV-2, highlighting the growing adoption of CRISPR technology in diagnostics.
Customize report:https://www.datamintelligence.com/customize/genome-editing-market
Genome Editing Market is segmentations
By Technology :CRISPR/CA’s, TALEN, Zinc Finger Nuclease (ZFN), and Others
By Application :Cell Line Engineering, Plant Genetic Engineering, Animal Genetic
By End User :Government & Academic Research Institutes, Biotech & Pharmaceutical Companies, and Contract Research Organizations.
Related Reports:
Agrigenomics
Epigenetics
Organoids
Market Major Players
GenScript USA Inc., Horizon Discovery Group plc, Integrated DNA Technologies Inc., Lonza Group Ltd, Merck & Co., New England Biolabs Inc., Origene Technologies Inc., Sangamo Biosciences Inc., Thermo Fisher Scientific Inc., Transposagen Biopharmaceuticals Inc., among others.
Contact Us:
Company Name: DataM Intelligence
Contact Person: Sai.K
Email: info@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About DataM Intelligence:
DataM Intelligence 4Market Research is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
English
Arabic
Français
Español
Português
Deutsch
Türkçe
Italiano
Russian
Romaian